Literature DB >> 20186549

Possible mechanisms of sudden cardiac death in top athletes: a basic cardiac electrophysiological point of view.

András Varró1, István Baczkó.   

Abstract

Sudden death among athletes is very rare (1:50,000-1:100,000 annually) but it is still 2-4 times more frequent than in the age-matched control population and attracts significant media attention. We propose a mechanism underlying sudden cardiac death in athletes that does not relate to myocardial ischemia but is based on repolarization abnormalities due to potassium channel downregulation and can also be best explained by the concurrent presence of several factors such as cardiac hypertrophy (athlete's heart), and/or hypertrophic cardiomyopathy, increased sympathetic tone, genetic defects, drugs, doping agents, food, or dietary ingredients. These factors together can increase the repolarization inhomogeneity of the heart ("substrate") and an otherwise harmless extrasystole ("trigger") occurring with a very unfortunate timing may sometimes induce life-threatening arrhythmias. The effective and possible prevention of sudden cardiac death requires the development of novel cost effective cardiac electrophysiological screening methods. Athletes identified by these tests as individuals at higher proarrhythmic risk should then be subjected to more costly genetic tests in order to uncover possible underlying genetic causes for alterations in ionic channel structure and/or function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186549     DOI: 10.1007/s00424-010-0798-0

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  53 in total

1.  QT dispersion in exercise-induced myocardial hypertrophy.

Authors:  M Halle; M Huonker; S H Hohnloser; M Alivertis; A Berg; J Keul
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

2.  Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes.

Authors:  P G Volders; K R Sipido; M A Vos; R L Spätjens; J D Leunissen; E Carmeliet; H J Wellens
Journal:  Circulation       Date:  1999-12-14       Impact factor: 29.690

Review 3.  Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.

Authors:  Domenico Corrado; Antonio Pelliccia; Hans Halvor Bjørnstad; Luc Vanhees; Alessandro Biffi; Mats Borjesson; Nicole Panhuyzen-Goedkoop; Asterios Deligiannis; Erik Solberg; Dorian Dugmore; Klaus P Mellwig; Deodato Assanelli; Pietro Delise; Frank van-Buuren; Aris Anastasakis; Hein Heidbuchel; Ellen Hoffmann; Robert Fagard; Silvia G Priori; Cristina Basso; Eloisa Arbustini; Carina Blomstrom-Lundqvist; William J McKenna; Gaetano Thiene
Journal:  Eur Heart J       Date:  2005-02-02       Impact factor: 29.983

4.  Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome.

Authors:  Fadi G Akar; Gan-Xin Yan; Charles Antzelevitch; David S Rosenbaum
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

5.  Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling.

Authors:  M A Vos; S H de Groot; S C Verduyn; J van der Zande; H D Leunissen; J P Cleutjens; M van Bilsen; M J Daemen; J J Schreuder; M A Allessie; H J Wellens
Journal:  Circulation       Date:  1998-09-15       Impact factor: 29.690

6.  Cardiac effects of anabolic steroids.

Authors:  J R Payne; P J Kotwinski; H E Montgomery
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 7.  Electrophysiological changes in heart failure and their relationship to arrhythmogenesis.

Authors:  Michiel J Janse
Journal:  Cardiovasc Res       Date:  2004-02-01       Impact factor: 10.787

8.  Screening for hypertrophic cardiomyopathy in young athletes.

Authors:  D Corrado; C Basso; M Schiavon; G Thiene
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

9.  In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.

Authors:  David J Gallacher; André Van de Water; Henk van der Linde; An N Hermans; Hua Rong Lu; Rob Towart; Paul G A Volders
Journal:  Cardiovasc Res       Date:  2007-06-29       Impact factor: 10.787

Review 10.  Exercise-induced cardiac hypertrophy: a substrate for sudden death in athletes?

Authors:  G Hart
Journal:  Exp Physiol       Date:  2003-09       Impact factor: 2.969

View more
  16 in total

Review 1.  Is the 'athlete's heart' arrhythmogenic? Implications for sudden cardiac death.

Authors:  Thomas Rowland
Journal:  Sports Med       Date:  2011-05-01       Impact factor: 11.136

Review 2.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

3.  Sudden cardiac death in low- and middle-income countries.

Authors:  Rajesh Vedanthan; Valentin Fuster; Avi Fischer
Journal:  Glob Heart       Date:  2012-12-05

4.  Ca2+-activated Cl- current is antiarrhythmic by reducing both spatial and temporal heterogeneity of cardiac repolarization.

Authors:  Bence Hegyi; Balázs Horváth; Krisztina Váczi; Mónika Gönczi; Kornél Kistamás; Ferenc Ruzsnavszky; Roland Veress; Leighton T Izu; Ye Chen-Izu; Tamás Bányász; János Magyar; László Csernoch; Péter P Nánási; Norbert Szentandrássy
Journal:  J Mol Cell Cardiol       Date:  2017-06-29       Impact factor: 5.000

5.  Detailed heart rate variability analysis in athletes.

Authors:  Orsolya Kiss; Nóra Sydó; Péter Vargha; Hajnalka Vágó; Csilla Czimbalmos; Eszter Édes; Endre Zima; Györgyi Apponyi; Gergő Merkely; Tibor Sydó; Dávid Becker; Thomas G Allison; Béla Merkely
Journal:  Clin Auton Res       Date:  2016-06-06       Impact factor: 4.435

Review 6.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

7.  Sudden cardiac death athletes: a systematic review.

Authors:  Marcelo Ferreira; Paulo Roberto Santos-Silva; Luiz Carlos de Abreu; Vitor E Valenti; Vanessa Crispim; Caio Imaizumi; Celso Ferreira Filho; Neif Murad; Adriano Meneghini; Andrés R Pérez Riera; Tatiana Dias de Carvalho; Luiz Carlos Marques Vanderlei; Erica E Valenti; José R Cisternas; Oseas F Moura Filho; Celso Ferreira
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2010-08-03

8.  Increased short-term variability of the QT interval in professional soccer players: possible implications for arrhythmia prediction.

Authors:  Csaba Lengyel; Andrea Orosz; Péter Hegyi; Zsolt Komka; Anna Udvardy; Edit Bosnyák; Emese Trájer; Gábor Pavlik; Miklós Tóth; Tibor Wittmann; Julius Gy Papp; András Varró; István Baczkó
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

9.  Noninvasive cardiac screening in young athletes with ventricular arrhythmias.

Authors:  Alexandros Klavdios Steriotis; Andrea Nava; Ilaria Rigato; Elisa Mazzotti; Luciano Daliento; Gaetano Thiene; Cristina Basso; Domenico Corrado; Barbara Bauce
Journal:  Am J Cardiol       Date:  2012-12-06       Impact factor: 2.778

10.  Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve.

Authors:  Attila Kristóf; Zoltán Husti; István Koncz; Zsófia Kohajda; Tamás Szél; Viktor Juhász; Péter Biliczki; Norbert Jost; István Baczkó; Julius Gy Papp; András Varró; László Virág
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.